Eli Lilly (LLY) Cash from Operations (2009 - 2026)

Eli Lilly (LLY) has reported Cash from Operations for 18 consecutive years, with 5333000000.0 the latest figure, recorded in Q1 2026.

• Cash from Operations for Q1 2026 came in at 5333000000.0, up 220.11% year-over-year; the trailing twelve-month figure through Mar 2026 was 20480000000.0 (up 119.79% YoY), and the FY2025 annual result was 16813000000.0, up 90.67% from the prior year.
• Cash from Operations was 5333000000.0 for Q1 2026 at Eli Lilly, up from 3224600000.0 in the prior quarter.
• Over five years, Cash from Operations peaked at 8835900000.0 in Q3 2025 and troughed at 312000000.0 in Q4 2023.
• Average Cash from Operations over 5 years is 2517041176.47, with a median of 2189500000.0 recorded in 2023.
• Year-over-year, Cash from Operations plunged 118.76% in 2023 and jumped 892.92% in 2024.
• Over 5 years, Cash from Operations stood at 1662700000.0 in 2022, then sank by 118.76% to 312000000.0 in 2023, then surged by 892.92% to 2473900000.0 in 2024, then soared by 30.34% to 3224600000.0 in 2025, then soared by 65.38% to 5333000000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 5333000000.0 in Q1 2026, 3224600000.0 in Q4 2025, and 8835900000.0 in Q3 2025.